Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gustavo Oderich

Vascular Surgery Houston, TX Medical Doctor

NPI 1740254515 CMS profile 260170

7200 Cambridge St, Houston, TX 77030

Open in the dashboard

General payments

$319,171

521 records reported · program years 2019–2025

Research payments

$322,957

Paid to them · 48 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$679,437 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Gustavo Oderich of Houston, TX is reported in the CMS Open Payments database as having received $319,171 across 521 general payments and $322,957 in research payments paid to them. Separately, studies naming them as principal investigator received $679,437 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $47,952 66
2025 Research $71,480 4
2024 General $48,178 55
2024 Research $51,650 4
2023 General $62,621 101
2023 Research $86,205 8
2022 General $98,481 103
2022 Research $43,245 8
2021 General $38,111 92
2021 Research $47,210 7
2020 General $4,410 40
2020 Research $23,167 17
2019 General $19,418 64

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gustavo Oderich
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Gustavo Oderich were reported at $47,952. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Gustavo Oderich Vascular Surgery median Middle half National median
2019 $19,418 $796 $226–$2,363 $163
2020 $4,410 $348 $118–$1,110 $114
2021 $38,111 $471 $158–$1,421 $132
2022 $98,481 $725 $222–$2,183 $149
2023 $62,621 $836 $257–$2,440 $160
2024 $48,178 $909 $252–$2,619 $164
2025 $47,952 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. W. L. Gore & Associates, Inc. $183,758 316 payments
  2. Cook Incorporated $48,136 23 payments
  3. Ge Healthcare $39,824 35 payments
  4. Cook Medical LLC $21,438 89 payments
  5. Bolton Medical Inc $12,047 5 payments
  6. Centerline Biomedical Inc. $7,779 3 payments
  7. Medtronic, Inc. $923 10 payments
  8. Cook Research Incorporated $842 3 payments
  9. CryoLife, Inc. $800 1 payment
  10. Atrium Medical Corporation $575 4 payments
  11. Other $3,048 32 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $183,788 73 payments
  2. Travel and Lodging $55,133 81 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $35,111 13 payments
  4. Food and Beverage $27,109 342 payments
  5. Honoraria $17,510 5 payments
  6. Education $303 3 payments
  7. Grant $217 4 payments
Products named General payments · program years 2019–2025
  1. Product in Development $82,425 35 payments
  2. GORE EXCLUDER Iliac Branch Endoprosthesis $42,232 35 payments
  3. Zenith Alpha $31,046 34 payments
  4. GORE TAG Thoracic Branch Endoprosthesis $28,051 46 payments
  5. EXCLUDER Conformable AAA Endoprosthesis with Active Control $27,487 18 payments
  6. C3 Delivery System $17,770 16 payments
  7. GORE DRYSEAL FLEX Introducer Sheath $16,112 5 payments
  8. Zenith $15,757 15 payments
  9. GORE EXCLUDER AAA Endoprosthesis $15,688 20 payments
  10. GORE VIABAHN VBX Balloon Expandable Endo $14,575 74 payments
  11. Other $79,550 224 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Cook Research Incorporated $322,957 48 payments

Billing to Medicare

Part B · data year 2024 · 59 billing codes

Paid by Medicare

$128,047

Medicare's payments for the services billed

Medicare patients

132

Average age 75

Services billed

264

46 women, 86 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 68%
Chronic kidney disease 49%
Arthritis 43%
Heart failure 39%
Atrial fibrillation 37%
COPD 37%
Diabetes 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

569 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record